The review concluded that low-carbohydrate, low-GI, Mediterranean and high-protein diets were effective at improving various markers of cardiovascular risk in people with diabetes. In view of the potential for bias in the systematic review process and the included studies, along with the significant heterogeneity between studies, these conclusions may not be reliable.
Twenty RCTs (3,073) were included in the review, of which 16 were pooled using meta-analysis. The method of randomisation was reported in 17 RCTs, 10 RCTs reported the method of allocation concealment and six RCTs analysed data on an intention-to-treat basis.
The following diets resulted in a statistically significantly greater improvement in glycaemic control than control diets: low-carbohydrate (Hb A1c reduction of -0.12%, 95% CI -0.24 to -0.00; eight RCTs; Ι²=75%); low-GI (-0.14%, 95% CI -0.24 to -0.03; three RCTs; Ι²=80%); Mediterranean (-0.41%, 95% CI -0.58 to -0.24; three RCTs; Ι²=82%); and highprotein (-0.28%, 95% CI -0.38 to -0.18; two RCTs; Ι²=60%). There was evidence of significant heterogeneity between trial results.
The Mediterranean diet also led to greater weight loss than control diets; -1.84 kg (95% CI -2.54 to -1.15). There was no statistically significant difference in weight loss with low-carbohydrate, low-GI and high-protein diets compared with control diets.
HDL was increased with the low-carbohydrate, low-GI and Mediterranean diets, compared with control diets, but not with the high-protein diet. The Mediterranean diet also significantly reduced triglycerides.
Results of individual studies that were not included in the meta-analysis were also presented.
Authors' conclusions
Low-carbohydrate, low-GI, Mediterranean and high-protein diets were effective at improving various markers of cardiovascular risk in people with diabetes.
CRD commentary
The review question and inclusion criteria were clear. The search strategy appeared to have been adequate, although it was unclear whether any language or publication status restrictions were applied. It was unclear whether attempts were made to minimise error and bias during study selection, data extraction and quality assessment procedures. Many of the included studies failed to report the method of allocation concealment and blinding of outcome assessors, so the included studies may have been biased. There were differences between studies in terms of the diets assessed (the specific macronutrient composition) and study participants' baseline characteristics (such as weight and Hb A 1c ), which means that statistical pooling of the studies may not have been appropriate. In addition, some of the control diets included aspects of the diets being evaluated. There was significant heterogeneity between study results. The clinical significance of many of the results was not reported, other than an acknowledgement that the reduction in glycaemic control with a low-GI diet (0.14%) may not be clinically significant.
In view of the potential for bias in the systematic review process and the included studies, along with the significant heterogeneity between studies, the authors' conclusions may not be reliable.
Implications of the review for practice and research
Practice: The authors stated that low-carbohydrate, low-GI, Mediterranean and high-protein diets should be considered in the overall strategy of diabetes management. However, dietary behaviours and choices are often personal, so dietary modification should be individualised rather than standard for all patients. There may be a range of beneficial dietary options for people with type 2 diabetes.
Research: The authors stated that large trials comparing all of these diets in participants with similar characteristics were required. In order to separate the effect of the diet from the effect of weight loss on markers of cardiovascular risk, future studies should aim to keep weight constant or ensure an equal caloric intake in all study arms. In addition, further research should be done to determine whether vegan and vegetarian diets were beneficial for people with diabetes.
